APA (7th ed.) Citation

Alfalasi, A., Ameen, A., Al Lafi, A., El Gendi, A., Saad, W., Ismail, A., . . . Almesfer, A. (2025). A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries. Journal of Dermatological Treatment, 36(1), 1. https://doi.org/10.1080/09546634.2024.2443110

Chicago Style (17th ed.) Citation

Alfalasi, Amani, et al. "A Real-world Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Patients Receiving Dupilumab Therapy, with Atopic Dermatitis Control Tool in Gulf Countries." Journal of Dermatological Treatment 36, no. 1 (2025): 1. https://doi.org/10.1080/09546634.2024.2443110.

MLA (9th ed.) Citation

Alfalasi, Amani, et al. "A Real-world Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Patients Receiving Dupilumab Therapy, with Atopic Dermatitis Control Tool in Gulf Countries." Journal of Dermatological Treatment, vol. 36, no. 1, 2025, p. 1, https://doi.org/10.1080/09546634.2024.2443110.